Insider Selling: Biosyent Inc. (RX) Director Sells 1,500 Shares of Stock
Biosyent Inc. (CVE:RX) Director Douglas Robert Larson sold 1,500 shares of the business’s stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of C$9.20, for a total value of C$13,800.00.
Douglas Robert Larson also recently made the following trade(s):
- On Friday, September 15th, Douglas Robert Larson sold 200 shares of Biosyent stock. The shares were sold at an average price of C$9.25, for a total value of C$1,850.00.
- On Wednesday, June 21st, Douglas Robert Larson sold 1,000 shares of Biosyent stock. The shares were sold at an average price of C$8.10, for a total value of C$8,100.00.
- On Monday, June 19th, Douglas Robert Larson sold 100 shares of Biosyent stock. The stock was sold at an average price of C$8.05, for a total value of C$805.00.
BioSyent Inc is a specialty pharmaceutical company. The Company, through its subsidiary, BioSyent Pharma Inc, acquires or in-licenses and develops pharmaceutical products for sale in Canada and certain international markets. It has four business units: the Community and Women’s Health Unit, which commercializes pharmaceutical products focused on improving family and women’s health; the Hospital Business Unit, which sells pharmaceutical products to hospitals and hospital specialists; the International Pharmaceutical Unit, and the Legacy Business.
Receive News & Ratings for Biosyent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biosyent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.